Literature DB >> 7916557

Spectrum of activity of soluble intercellular adhesion molecule-1 against rhinovirus reference strains and field isolates.

A Ohlin1, H Hoover-Litty, G Sanderson, A Paessens, S L Johnston, S T Holgate, E Huguenel, J M Greve.   

Abstract

The antiviral potency of soluble intercellular adhesion molecule-1 (ICAM-1; the major receptor for human rhinoviruses) was determined for a subset of American Type Culture Collection reference serotypes and field isolates of rhinovirus. The results indicate that soluble ICAM-1 exhibits a broad spectrum of activity against rhinoviruses and that field isolates have a sensitivity indistinguishable from that of laboratory strains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916557      PMCID: PMC188221          DOI: 10.1128/AAC.38.6.1413

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4.

Authors:  M Ivey-Hoyle; J S Culp; M A Chaikin; B D Hellmig; T J Matthews; R W Sweet; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

2.  A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100.

Authors:  V V Hamparian; R J Colonno; M K Cooney; E C Dick; J M Gwaltney; J H Hughes; W S Jordan; A Z Kapikian; W J Mogabgab; A Monto
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

3.  Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses.

Authors:  R J Colonno; P L Callahan; W J Long
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  The Tecumseh study of respiratory illness. IV. Prevalence of rhinovirus serotypes, 1966-1969.

Authors:  A S Monto; J J Cavallaro
Journal:  Am J Epidemiol       Date:  1972-11       Impact factor: 4.897

5.  Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.

Authors:  J M Greve; C P Forte; C W Marlor; A M Meyer; H Hoover-Litty; D Wunderlich; A McClelland
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  The major human rhinovirus receptor is ICAM-1.

Authors:  J M Greve; G Davis; A M Meyer; C P Forte; S C Yost; C W Marlor; M E Kamarck; A McClelland
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

7.  A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses.

Authors:  D E Staunton; V J Merluzzi; R Rothlein; R Barton; S D Marlin; T A Springer
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms.

Authors:  S L Johnston; G Sanderson; P K Pattemore; S Smith; P G Bardin; C B Bruce; P R Lambden; D A Tyrrell; S T Holgate
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

9.  Rhinoviruses in Seattle families, 1975-1979.

Authors:  J P Fox; M K Cooney; C E Hall; H M Foy
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

10.  In vitro activity of R 61837, a new antirhinovirus compound.

Authors:  K Andries; B Dewindt; M De Brabander; R Stokbroekx; P A Janssen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

View more
  11 in total

1.  Comparative susceptibilities of human embryonic fibroblasts and HeLa cells for isolation of human rhinoviruses.

Authors:  E Arruda; C E Crump; B S Rollins; A Ohlin; F G Hayden
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

2.  Diagnosis of viral respiratory tract infections in children by using a reverse transcription-PCR panel.

Authors:  L L Gilbert; A Dakhama; B M Bone; E E Thomas; R G Hegele
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.

Authors:  B D Zelus; D R Wessner; R K Williams; M N Pensiero; F T Phibbs; M deSouza; G S Dveksler; K V Holmes
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  ICAM-1 Binding Rhinoviruses A89 and B14 Uncoat in Different Endosomal Compartments.

Authors:  Rick Conzemius; Haleh Ganjian; Dieter Blaas; Renate Fuchs
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 5.  Viral entry pathways: the example of common cold viruses.

Authors:  Dieter Blaas
Journal:  Wien Med Wochenschr       Date:  2016-05-12

6.  ICAM-1 Binding Rhinoviruses Enter HeLa Cells via Multiple Pathways and Travel to Distinct Intracellular Compartments for Uncoating.

Authors:  Haleh Ganjian; Christin Zietz; Diana Mechtcheriakova; Dieter Blaas; Renate Fuchs
Journal:  Viruses       Date:  2017-04-01       Impact factor: 5.048

Review 7.  The treatment of rhinovirus infections: progress and potential.

Authors:  R B Turner
Journal:  Antiviral Res       Date:  2001-01       Impact factor: 5.970

8.  Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.

Authors:  M D de Jong; C A Boucher; D A Cooper; G J Galasso; B Gazzard; J M Lange; J S Montaner; D D Richman; H C Thomas
Journal:  Antiviral Res       Date:  1997-07       Impact factor: 5.970

Review 9.  Anti-infective immunoadhesins from plants.

Authors:  Keith Wycoff; James Maclean; Archana Belle; Lloyd Yu; Y Tran; Chad Roy; Frederick Hayden
Journal:  Plant Biotechnol J       Date:  2015-08-04       Impact factor: 9.803

Review 10.  The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

Authors:  Judith M Rollinger; Michaela Schmidtke
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.